Paul Y. Song, Chief Executive Officer at NKGen Biotech, Inc. (NKGN), bought 243 shares at $2.85 ($701) on 2023-11-27, disclosed to the SEC on 2023-11-28.
Open-market purchase of $701 NKGN by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.85 | 140 | $400 | 57.1% |
| 2 | $2.91 | 103 | $300 | 42.9% |
| Total | $2.88 avg | 243 | $701 | 100% |
| Filing → |
| NKGN | BUY | 2023-12-05 | $850 | — | Filing → |
| NKGN | BUY | 2023-11-22 | $430 | — | Filing → |